Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Pharmacological Reviews
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Pharmacological Reviews

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit Pharm Rev on Facebook
  • Follow Pharm Rev on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

March 01, 1966; Volume 18,Issue 1
  • You have access
    FOREWORD
    George H. Acheson and Sidney Udenfriend
    Pharmacological Reviews March 1966, 18 (1) 3-4;
  • You have access
    NILS-ÅKE HILLARP
    Arvid Carlsson
    Pharmacological Reviews March 1966, 18 (1) 5-6;
  • You have access
    SIR JOHN GADDUM
    M. Vogt
    Pharmacological Reviews March 1966, 18 (1) 5;
  • You have access
    ROSEMARY CASS
    G. A. H. Buttle
    Pharmacological Reviews March 1966, 18 (1) 6-7;
  • You have access
    TWENTY YEARS OF NORADRENALINE
    U. S. von Euler
    Pharmacological Reviews March 1966, 18 (1) 29-38;
  • You have access
    A. INTRODUCTORY REMARKS
    H. Blaschko
    Pharmacological Reviews March 1966, 18 (1) 39-41;
  • You have access
    B. TYROSINE HYDROXYLASE
    Sidney Udenfriend
    Pharmacological Reviews March 1966, 18 (1) 43-51;
  • You have access
    C. DOPA DECARBOXYLASE: SUBSTRATES, COENZYME, INHIBITORS
    Theodore L. Sourkes
    Pharmacological Reviews March 1966, 18 (1) 53-60;
  • You have access
    D. COENZYMES AND HYDROXYLASES: ASCORBATE AND DOPAMINE-β-HYDROXYLASE; TETRAHYDROPTERIDINES AND PHENYLALANINE AND TYROSINE HYDROXYLASES
    Seymour Kaufman
    Pharmacological Reviews March 1966, 18 (1) 61-69;
  • You have access
    E. ENZYMIC STUDIES ON THE MECHANISM OF DOUBLE HYDROXYLATION
    Osamu Hayaishi
    Pharmacological Reviews March 1966, 18 (1) 71-75;
  • You have access
    F. INHIBITION OF NOREPINEPHRINE BIOSYNTHESIS AT THE DOPAMINE-β-HYDROXYLATION STAGE
    M. Goldstein
    Pharmacological Reviews March 1966, 18 (1) 77-82;
  • You have access
    G. SUMMARY OF DISCUSSION AND COMMENTARY
    N. Kirshner
    Pharmacological Reviews March 1966, 18 (1) 83-84;
  • You have access
    H. INTRODUCTORY REMARKS
    P. Holtz
    Pharmacological Reviews March 1966, 18 (1) 85-88;
  • You have access
    I. BIOSYNTHESIS OF CATECHOLAMINES IN INSECTS
    Constantin E. Sekeris and Peter Karlson
    Pharmacological Reviews March 1966, 18 (1) 89-94;
  • You have access
    J. METHYLATION REACTIONS IN THE FORMATION AND METABOLISM OF CATECHOLAMINES AND OTHER BIOGENIC AMINES
    Julius Axelrod
    Pharmacological Reviews March 1966, 18 (1) 95-113;
  • You have access
    K. MONOAMINE OXIDASES
    V. Z. Gorkin
    Pharmacological Reviews March 1966, 18 (1) 115-120;
  • You have access
    L. MONOAMINE OXIDASE INHIBITORS
    A. Pletscher
    Pharmacological Reviews March 1966, 18 (1) 121-129;
  • You have access
    M. STERIC EFFECTS IN CATECHOLAMINE INTERACTIONS WITH ENZYMES AND RECEPTORS
    B. Belleau
    Pharmacological Reviews March 1966, 18 (1) 131-140;
  • You have access
    N. SUMMARY OF DISCUSSION AND COMMENTARY
    E. A. Zeller
    Pharmacological Reviews March 1966, 18 (1) 141-143;
  • You have access
    SOME RECENT ADVANCES IN THE PURIFICATION OF MITOCHONDRIAL MONOAMINE OXIDASE
    S. Nara and K. T. Yasunobu
    Pharmacological Reviews March 1966, 18 (1) 144;
  • You have access
    A. THE ROLE OF CYCLIC-3',5'-AMP IN RESPONSES TO CATECHOLAMINES AND OTHER HORMONES
    Earl W. Sutherland and G. Alan Robison
    Pharmacological Reviews March 1966, 18 (1) 145-161;
  • You have access
    B. ACTIVATION OF SKELETAL MUSCLE PHOSPHORYLASE
    Edwin G. Krebs, Robert J. DeLange, Robert G. Kemp and W. Dixon Riley
    Pharmacological Reviews March 1966, 18 (1) 163-171;
  • You have access
    C. FACTORS INFLUENCING ACTIVATION OF PHOSPHOFRUCTOKINASE
    Tag E. Mansour
    Pharmacological Reviews March 1966, 18 (1) 173-179;
  • You have access
    D. THE STIMULATION OF GLUCONEOGENESIS FROM LACTATE BY EPINEPHRINE, GLUCAGON, AND CYCLIC 3',5'-ADENYLATE IN THE PERFUSED RAT LIVER
    J. H. Exton and C. R. Park
    Pharmacological Reviews March 1966, 18 (1) 181-188;
  • You have access
    E. THE ACTIVATION OF GLYCOLYSIS IN FROG SARTORIUS MUSCLE BY EPINEPHRINE
    Ernst Helmreich and Carl F. Cori
    Pharmacological Reviews March 1966, 18 (1) 189-196;
  • You have access
    F. THE INFLUENCE OF CATECHOLAMINES ON HEART FUNCTION AND PHOSPHORYLASE ACTIVITY
    Niels Haugaard and Marilyn E. Hess
    Pharmacological Reviews March 1966, 18 (1) 197-203;
  • You have access
    G. KINETIC STUDIES OF EPINEPHRINE EFFECTS IN THE PERFUSED RAT HEART
    John R. Williamson
    Pharmacological Reviews March 1966, 18 (1) 205-210;
  • You have access
    H. SUMMARY OF DISCUSSION AND COMMENTARY
    E. Bueding
    Pharmacological Reviews March 1966, 18 (1) 211-213;
  • You have access
    I. INTRODUCTORY REMARKS
    M. Vaughan
    Pharmacological Reviews March 1966, 18 (1) 215-216;
  • You have access
    J. CATECHOLAMINE STIMULATION OF FAT MOBILIZATION AND ITS METABOLIC CONSEQUENCES
    Daniel Steinberg
    Pharmacological Reviews March 1966, 18 (1) 217-235;
  • You have access
    K. CYCLIC 3',5'-AMP AND THE LIPOLYTIC EFFECTS OF HORMONES ON ADIPOSE TISSUE
    R. W. Butcher
    Pharmacological Reviews March 1966, 18 (1) 237-241;
  • You have access
    L. BLOOD AND TISSUE CHANGES INDUCED BY NOREPINEPHRINE-STIMULATED MOBILIZATION OF FREE FATTY ACIDS
    L. A. Carlson
    Pharmacological Reviews March 1966, 18 (1) 242;
  • You have access
    M. EFFECT OF DRUGS ON MOBILIZATION OF FREE FATTY ACID
    S. Garattini and A. Bizzi
    Pharmacological Reviews March 1966, 18 (1) 243-251;
  • You have access
    N. SUMMARY OF DISCUSSION AND COMMENTARY
    T. Brody
    Pharmacological Reviews March 1966, 18 (1) 253;
  • You have access
    O. INTRODUCTORY REMARKS
    Lennart Lundholm, Ella Mohme-Lundholm and Nils Svedmyr
    Pharmacological Reviews March 1966, 18 (1) 255-272;
  • You have access
    P. INTERRELATIONSHIPS OF CATECHOLAMINES WITH OTHER ENDOCRINE SYSTEMS
    B. B. Brodie, J. I. Davies, S. Hynie, G. Krishna and B. Weiss
    Pharmacological Reviews March 1966, 18 (1) 273-289;
  • You have access
    Q. THE ROLE OF CATECHOLAMINES IN COLD ADAPTATION
    Loren D. Carlson
    Pharmacological Reviews March 1966, 18 (1) 291-301;
  • You have access
    R. EFFECTS OF GLUCOSE DEPRIVATION ON THE SYMPATHETIC OUTFLOW TO THE ADRENAL MEDULLA AND ADIPOSE TISSUE
    Alan Goldfien
    Pharmacological Reviews March 1966, 18 (1) 303-311;
  • You have access
    S. SUMMARY OF DISCUSSION AND COMMENTARY
    Z. M. Bacq
    Pharmacological Reviews March 1966, 18 (1) 313-314;
  • You have access
    A. INTRODUCTORY REMARKS
    Marthe Vogt
    Pharmacological Reviews March 1966, 18 (1) 315-316;
  • You have access
    B. THE ESTIMATION OF CATECHOLAMINES BY BIOLOGICAL ASSAY
    J. R. Vane
    Pharmacological Reviews March 1966, 18 (1) 317-324;
  • You have access
    C. NEWER DEVELOPMENTS IN CATECHOLAMINE ASSAY
    Jan Häggendal
    Pharmacological Reviews March 1966, 18 (1) 325-329;
  • You have access
    D. THE ESTIMATION OF METANEPHRINE, NORMETANEPHRINE, AND 3,4-DIHYDROXYMANDELIC ACID IN URINE
    H. Weil-Malherbe and Elizabeth R. B. Smith
    Pharmacological Reviews March 1966, 18 (1) 331-341;
  • You have access
    E. THE MEASUREMENT OF 4-HYDROXY-3-METHOXYMANDELIC ACID AND HOMOVANILLIC ACID
    M. Sandler and C. R. J. Ruthven
    Pharmacological Reviews March 1966, 18 (1) 343-351;
  • You have access
    F. METHODOLOGY OF FLUORESCENCE MICROSCOPY OF CATECHOLAMINES
    Ch. Owman
    Pharmacological Reviews March 1966, 18 (1) 351;
  • You have access
    G. DEMONSTRATION OF CATECHOLAMINES AND CHOLINESTERASES IN THE SAME SECTION
    Olavi ErÄnkö
    Pharmacological Reviews March 1966, 18 (1) 353-358;
  • You have access
    H. SUMMARY OF DISCUSSION AND COMMENTARY
    G. B. Koelle
    Pharmacological Reviews March 1966, 18 (1) 359-364;
  • You have access
    A. INTRODUCTORY REMARKS
    U. S. Von Euler
    Pharmacological Reviews March 1966, 18 (1) 365-367;
  • You have access
    B. THE LOCALIZATION OF MONOAMINERGIC BLOOD-BRAIN BARRIER MECHANISMS
    A. Bertler, B. Falck, Ch. Owman and E. Rosengrenn
    Pharmacological Reviews March 1966, 18 (1) 369-385;
  • You have access
    C. ELECTRON MICROSCOPY OF SYMPATHETIC TISSUES
    Mary A. Grillo
    Pharmacological Reviews March 1966, 18 (1) 387-399;
  • You have access
    D. CATECHOLAMINE STORAGE PARTICLES IN THE CENTRAL NERVOUS SYSTEM
    V. P. Whittaker
    Pharmacological Reviews March 1966, 18 (1) 401-412;
  • You have access
    E. ADRENERGIC ENDINGS AND VESICLES ISOLATED FROM BRAIN
    Eduardo De Robertis
    Pharmacological Reviews March 1966, 18 (1) 413-424;
  • You have access
    F. STORAGE PARTICLES IN NORADRENERGIC TISSUES
    Lennart Stjärne
    Pharmacological Reviews March 1966, 18 (1) 425-432;
  • You have access
    G. MEDULLARY PARTICLES
    Hans-Joachim Schümann
    Pharmacological Reviews March 1966, 18 (1) 433-438;
  • You have access
    H. STORAGE OF NOREPINEPHRINE IN SYMPATHETIC NERVES
    Lincoln T. Potter
    Pharmacological Reviews March 1966, 18 (1) 439-451;
  • You have access
    I. CHROMAFFIN TISSUE
    P. Banks and H. Blaschko
    Pharmacological Reviews March 1966, 18 (1) 453-456;
  • You have access
    J. SUMMARY OF DISCUSSION AND COMMENTARY
    E. W. Maynert
    Pharmacological Reviews March 1966, 18 (1) 457-458;
  • You have access
    A. INTRODUCTORY REMARKS
    J. H. Burn
    Pharmacological Reviews March 1966, 18 (1) 459-470;
  • You have access
    B. THE MECHANISM OF RELEASE OF CATECHOLAMINES FROM THE ADRENAL MEDULLA
    W. W. Douglas
    Pharmacological Reviews March 1966, 18 (1) 471-480;
  • You have access
    C. JUNCTION POTENTIALS AT ADRENERGIC SYNAPSES
    G. Burnstock and Mollie E. Holman
    Pharmacological Reviews March 1966, 18 (1) 481-493;
  • You have access
    D. CALCIUM AND THE RELAXANT EFFECT OF ISOPROTERENOL IN THE DEPOLARIZED RAT UTERUS
    H. O. Schild
    Pharmacological Reviews March 1966, 18 (1) 495-501;
  • You have access
    E. PHARMACOLOGICAL CHARACTERIZATION OF ADRENERGIC RECEPTORS
    Neil C. Moran
    Pharmacological Reviews March 1966, 18 (1) 503-512;
  • You have access
    F. BIOCHEMICAL ASPECTS OF RELEASE OF NOREPINEPHRINE AND OTHER AMINES FROM SYMPATHETIC NERVE ENDINGS
    Irwin J. Kopin
    Pharmacological Reviews March 1966, 18 (1) 513-523;
  • You have access
    G. THE MECHANISM OF UPTAKE OF NOREPINEPHRINE
    Elwood Titus and Hans J. Dengler
    Pharmacological Reviews March 1966, 18 (1) 525-535;
  • You have access
    H. SUMMARY OF DISCUSSION AND COMMENTARY
    J. S. Gillespie
    Pharmacological Reviews March 1966, 18 (1) 537-540;
  • You have access
    A. PHARMACOLOGICAL DEPLETION OF CATECHOLAMINE STORES
    Arvid Carlsson
    Pharmacological Reviews March 1966, 18 (1) 541-549;
  • You have access
    B. INDIRECTLY ACTING SYMPATHOMIMETIC AMINES
    E. Muscholl
    Pharmacological Reviews March 1966, 18 (1) 551-559;
  • You have access
    C. THE MECHANISM OF NOREPINEPHRINE DEPLETION BY RESERPINE, METARAMINOL AND RELATED AGENTS. THE ROLE OF MONOAMINE OXIDASE
    P. A. Shore
    Pharmacological Reviews March 1966, 18 (1) 561-568;
  • You have access
    D. METHYLDOPA AND ADRENERGIC NERVE FUNCTION
    Clement A. Stone and Curt C. Porter
    Pharmacological Reviews March 1966, 18 (1) 569-575;
  • You have access
    E. INTERACTIONS OF DRUGS WITH ADRENERGIC NEURONS
    E. Costa, D. J. Boullin, W. Hammer, W. Vogel and B. B. Brodie
    Pharmacological Reviews March 1966, 18 (1) 577-597;
  • You have access
    F. INHIBITORS OF ENDOGENOUS CATECHOLAMINE BIOSYNTHESIS
    Sydney Spector
    Pharmacological Reviews March 1966, 18 (1) 599-609;
  • You have access
    G. SURGICAL SYMPATHECTOMY AND ADRENERGIC FUNCTION
    Theodore Cooper
    Pharmacological Reviews March 1966, 18 (1) 611-618;
  • You have access
    H. IMMUNOSYMPATHECTOMY
    Rita Levi-Montalcini and Pietro U. Angeletti
    Pharmacological Reviews March 1966, 18 (1) 619-628;
  • You have access
    I. MECHANISMS OF SUPERSENSITIVITY AND SUBSENSITIVITY TO SYMPATHOMIMETIC AMINES
    U. Thendelenburg
    Pharmacological Reviews March 1966, 18 (1) 629-640;
  • You have access
    J. SUMMARY OF DISCUSSION AND COMMENTARY
    R. F. Furchgott
    Pharmacological Reviews March 1966, 18 (1) 641-644;
  • You have access
    A. CHEMISTRY AND PHARMACOLOGY OF CATECHOLAMINE-SECRETING TUMORS
    Wilfried von Studnitz
    Pharmacological Reviews March 1966, 18 (1) 645-650;
  • You have access
    B. PHEOCHROMOCYTOMA
    J. Richard Crout
    Pharmacological Reviews March 1966, 18 (1) 651-657;
  • You have access
    C. CATECHOLAMINE-PRODUCING NEURAL TUMORS OTHER THAN PHEOCHROMOCYTOMA
    Hans Käser
    Pharmacological Reviews March 1966, 18 (1) 659-665;
  • You have access
    D. CATECHOLAMINES AND HYPERTENSION
    W. S. Peart
    Pharmacological Reviews March 1966, 18 (1) 667-672;
  • You have access
    E. CATECHOLAMINE-DRUG INTERACTIONS IN MAN
    Albert Sjoerdsma
    Pharmacological Reviews March 1966, 18 (1) 673-683;
  • You have access
    F. SYMPATHETIC ACTIVITY AND NEUROTRANSMITTER DEPLETION IN CONGESTIVE HEART FAILURE
    Charles A. Chidsey and Eugene Braunwald
    Pharmacological Reviews March 1966, 18 (1) 685-700;
  • You have access
    G. ADRENERGIC BLOCKADE IN CARDIOVASCULAR DISEASE
    A. C. Dornhorst
    Pharmacological Reviews March 1966, 18 (1) 701-703;
  • You have access
    H. CARDIOVASCULAR EFFECTS OF MONOAMINE OXIDASE INHIBITORS
    B. Nikodijević, E. Glavaš and M. Polenaković
    Pharmacological Reviews March 1966, 18 (1) 705;
  • You have access
    I. SUMMARY OF DISCUSSION AND COMMENTARY
    S. E. Gitlow
    Pharmacological Reviews March 1966, 18 (1) 707-711;
  • You have access
    A. INTRODUCTORY REMARKS
    W. Feldberg
    Pharmacological Reviews March 1966, 18 (1) 713-716;
  • You have access
    B. CENTRAL ADRENERGIC SYNAPSES
    G. C. Salmoiraghi
    Pharmacological Reviews March 1966, 18 (1) 717-726;
  • You have access
    C. DEMONSTRATION AND MAPPING OF CENTRAL NEURONS CONTAINING DOPAMINE, NORADRENALINE, AND 5-HYDROXYTRYPTAMINE AND THEIR REACTIONS TO PSYCHOPHARMACA
    N.-Å. Hillarp, Kjell Fuxe and Annica Dahlström
    Pharmacological Reviews March 1966, 18 (1) 727-741;
  • You have access
    D. NEW POSSIBILITIES FOR ADRENERGIC MODULATION OF GANGLIONIC TRANSMISSION
    Karl-Axel Norberg and Folke Sjöqvist
    Pharmacological Reviews March 1966, 18 (1) 743-751;
  • You have access
    E. BEHAVIOURAL AND ELECTROPHYSIOLOGICAL EFFECTS OF CATECHOLAMINES
    E. Marley
    Pharmacological Reviews March 1966, 18 (1) 753-768;
  • You have access
    F. POSSIBLE ROLE OF BRAIN DOPAMINE
    Åke Bertler and Evald Rosengren
    Pharmacological Reviews March 1966, 18 (1) 769-773;
  • You have access
    G. EFFECTS OF DRUGS ON THE DISPOSITION OF H3-NOREPINEPHRINE IN THE RAT BRAIN
    J. Glowinski and J. Axelrod
    Pharmacological Reviews March 1966, 18 (1) 775-785;
  • You have access
    H. CATECHOLAMINES IN NEUROPSYCHIATRIC STATES
    Seymour S. Kety
    Pharmacological Reviews March 1966, 18 (1) 787-798;
  • You have access
    I. ADRENERGIC ACTIVATION BY ANTICHOLINESTERASES
    V. Varagić and M. Krstić
    Pharmacological Reviews March 1966, 18 (1) 799-800;
  • You have access
    J. SUMMARY OF DISCUSSION AND COMMENTARY
    M. Nickerson
    Pharmacological Reviews March 1966, 18 (1) 801-803;
  • You have access
    MECHANISMS OF CHEMICAL CARCINOGENESIS: NATURE OF PROXIMATE CARCINOGENS AND INTERACTIONS WITH MACROMOLECULES
    ELIZABETH C. MILLER and JAMES A. MILLERE
    Pharmacological Reviews March 1966, 18 (1) 805-838;
  • You have access
    MODIFICATION BY DRUGS OF SYNAPTIC MECHANISMS IN AUTONOMIC GANGLIA
    ROBERT L. VOLLE
    Pharmacological Reviews March 1966, 18 (1) 839-869;
  • You have access
    RELATIONSHIPS BETWEEN ANTHELMINTIC EFFECTS AND BIOCHEMICAL AND PHYSIOLOGICAL MECHANISMS
    HOWARD J. SAZ and ERNEST BUEDING
    Pharmacological Reviews March 1966, 18 (1) 871-894;
  • You have access
    DRUGS USED IN MOTION SICKNESS
    J. J. BRAND and W. L. M. PERRY
    Pharmacological Reviews March 1966, 18 (1) 895-924;
Back to top
PreviousNext

In this issue

Pharmacological Reviews
Vol. 18, Issue 1
1 Mar 1966
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Nitric oxide: physiology, pathophysiology, and pharmacology.
  • The Glutamate Receptor Ion Channels
  • Receptors for Purines and Pyrimidines
  • Evolving Concepts in G Protein-Coupled Receptor Endocytosis: The Role in Receptor Desensitization and Signaling
  • Glutamate Receptor Ion Channels: Structure, Regulation, and Function
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Pharmacological Reviews
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacology Research & Perspectives
ISSN 1521-0081 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics